NeuroStar TMS Therapy, a Non-Drug Depression Treatment, Demonstrates Statistically Significant Benefits on Patient-Reported Pain Outcomes Study Participants Experienced Improvement in Pain and Well-Being that Persisted Through One Year SAN DIEGO, March 19, 2013 – New...
Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer Hematology / oncology industry expert to lead promising development pipeline BOULDER, Colo., March 21, 2013 /PRNewswire/ — Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company...
VaxInnate Awarded U.S. Government Grant to Develop Dengue Vaccine Mosquito-borne disease identified as emerging public health threat for Americans CRANBURY, NJ, April 4, 2013 – VaxInnate Corporation announced today that it has been awarded a grant by the National...
MEI Pharma Announces $15.2 Million Registered Offering of Common Stock San Diego – April 5, 2013 – MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today an underwritten registered...
NxStage Completes Move to Direct Sales In UK Company to Leverage Recent CE Mark Approvals for System One Innovations LAWRENCE, Mass., April 8, 2013 /PRNewswire/ — NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products,...
iRhythm Secures $16 Million in Funding Led by Norwest Venture Partners to Fuel Continued Market and Technology Expansion Adoption of Zio Patch System Reaches New Milestone – Greater Than 20 Million Patient Hours of Monitoring SAN FRANCISCO – April 10, 2013 –...
Recent Comments